A CLEARER PICTURE, BEFORE EVERY VISIT
Every record.
One whole
person.
A source-linked patient briefing for clinicians. Connected across time. Built around how you practice.
Source-linked. Practitioner-reviewed.
ONE CONNECTED PATIENT HISTORY
- Penicillin allergy
- Type 2 diabetes
- HbA1c 7.1%
- Short stay
- HbA1c 8.2%
Illustrative patient history drawn from the demo timeline: penicillin allergy in 2018, type 2 diabetes in 2019, HbA1c 7.1% in 2022, a short hospital stay in 2024, and HbA1c 8.2% in 2026. All records shown are synthetic.
The record is only
the beginning.
Ordeva connects to your EMR/EHR and brings labs, genetics, notes, and outside records into one personalized, source-linked briefing—shaped around how you practice, with every decision still in your hands.
BRING THE RECORD TOGETHER
Different sources.
A connected view.
Authorized EHR information, laboratory reports, genetics, and outside documents each add context to the patient story.
Your EHR remains the system for charting, ordering, prescribing, and billing.
THE DETAILS THAT CHANGE THE PICTURE
See the change.
Understand the context.
Follow a biomarker across time. Open the underlying result, then consider it alongside the patient’s wider history.
Measurements stay connected to their source and date. Synthetic demonstration.
Top 10 Priorities — Next 90 Days
Hover a rank to see that priority — click to open it on the chart
1 · ACT
Factor adipogenesis genetics into intensity
- Adipogenesis is VERY HIGH on file — this changes how hard to treat and how closely to monitor, not whether to act. Clinician chooses agents and dose.
THE PATIENT BRIEFING
Prepared for
the conversation.
Move from the timeline to a summary, current priorities, plan, follow-up, and reference information in one workspace.
YOUR CLINICAL APPROACH
Built around
how you practice.
Your methodology gives the briefing its perspective. Review the information through the priorities and evidence you use in practice.
EVIDENCE AND OVERSIGHT
Follow the source.
Keep the decision.
Every finding stays tied to the patient record and the clinical literature behind it. Plans stay in draft until you review and approve what gets shared.
SOURCES
Patient facts and clinical evidence
See what came from this patient’s chart, and what came from supporting clinical literature—kept separate, so you can inspect both before you act.
- Original labs, notes, and records linked inline
- Supporting evidence shown beside each finding
- Clear separation between patient data and literature
APPROVAL
Draft, review, then share
Ordeva can organize a post-visit plan draft from your inputs and visit decisions. You decide what is approved, and release status stays explicit until you say otherwise.
CLINICAL WORKFLOW, CLEAR RESPONSIBILITIES
Trust needs
specific answers.
Understand the operating model, review process, and safeguards before bringing patient information into the platform.
Before processing PHI
A signed Business Associate Agreement and completed production-security review are required before processing PHI for a covered clinic.
Access and traceability
The published security program describes role-based access, MFA, encryption, and audit logging, subject to production verification.
Independent assurance
Penetration testing and SOC 2 readiness are on the roadmap. Ordeva does not currently claim SOC 2 or HITRUST certification.
SEE ORDEVA IN CONTEXT
A clearer picture.
A more prepared practice.
Arrange a walkthrough for your team, or see how Ordeva fits into clinical workflow.